Navigation Links
Horizon Pharma, Inc. Announces FDA Acceptance of DUEXA(R) New Drug Application for Filing
Date:5/26/2010

ication (MAA) for DUEXA in the European Union through the Decentralized Procedure in the second half of 2010.

About DUEXA

DUEXA is a novel, proprietary fixed-dose tablet combining the one of the world's most prescribed NSAIDs, ibuprofen, with a high dose of the most potent H2 antagonist, famotidine, in a single pill.  Ibuprofen has proven anti-inflammatory and analgesic properties, whereas famotidine reduces the stomach acid secretion that can cause gastric and duodenal ulceration.   By combining ibuprofen and famotidine into a single product, it is believed that ibuprofen's gastrointestinal safety profile will be improved without altering its ability to reduce pain and inflammation.

About the Arthritis and Pain Market

According to the Arthritis Foundation, arthritis affects 46 million people in the U.S. and costs the U.S. economy $128 billion annually.  According to a study by the Centers for Disease Control and Prevention (CDC) for the National Arthritis Data Workgroup, due to the increasing aging population, arthritis is projected to increase by 40 percent in the next two decades.  The CDC estimates that 67 million people in the U.S. will be affected by arthritis by 2030.  Additionally, chronic pain affects an estimated 86 million American adults. NSAIDs are among the most widely used drugs in the world for the treatment of arthritis and pain and are a major cause of GI complications, including ulcers. NSAIDs block enzymes and reduce prostaglandins throughout the body and as a consequence, ongoing inflammation, pain, and fever are reduced.  Because the prostaglandins that protect the stomach are reduced, NSAIDs often cause ulcers in the stomach. NSAID-induced GI toxicity causes an estimated 16,500 deaths and more than 107,000 hospitalizations annually in the U
'/>"/>

SOURCE Horizon Pharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
2. Horizon Therapeutics HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
3. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
4. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
5. HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
6. Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501
7. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
8. Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501
9. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
10. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Receives New Research Grant From Hong Kong Innovation and Technology Commission
11. Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Calif. , June 19, 2013   ... improve sample standardization and handling in many areas ... issuance of new patents by the U.S. Patent ... thermo-conductive products developed to standardize sample handling to ... of results in common laboratory procedures. ...
(Date:6/19/2013)... BURLINGTON, Mass. , June 19, 2013 /PRNewswire/ ... and advisory firms for pharmaceutical and healthcare issues, ... the majority of surveyed U.S. and European rheumatologists ... of the attributes that most influences their prescribing ... U.S. and European rheumatologists, respectively, rank the percentage ...
(Date:6/19/2013)... /PRNewswire/ -- Chindex International, Inc. (NASDAQ: CHDX, "Chindex" or ... in China through the ... private hospitals and affiliated ambulatory clinics, today announced ... Rehabilitation Hospital ("BJU Rehab Hospital"), one of the ... ("UFH") network. On June 19, 2013, the Company ...
Breaking Medicine Technology:BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research 2U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5
... ALSO TUES., MAY 25 NOON—RIBBON CUTTING –OPENING NEW CANYON PARK TREATMENT SOLUTIONS, ... WA 98021, Suite 101 , , , ... Announce 96% Successful Stop of Opiate Abuse within 30 Days Treatment , ... TACOMA, Wash. and BOTHELL, Wash. , May 18 Four- Star General ...
... 18 Accuray Incorporated (Nasdaq: ARAY ), a global leader in ... joined Accuray as General Manager of the EIMEA (Europe India Middle East and ... , , ... healthcare device and supply company, where he served most recently as the EMEA ...
Cached Medicine Technology:4-Star General-Former U.S. Drug Czar Barry McCaffrey Featured At Tacoma Treatment Solutions 5-Year Anniv: Mon. May 24, 11 a.m., 9500 Front Street, Lakewood WA 98499 24-Star General-Former U.S. Drug Czar Barry McCaffrey Featured At Tacoma Treatment Solutions 5-Year Anniv: Mon. May 24, 11 a.m., 9500 Front Street, Lakewood WA 98499 3Accuray Hires General Manager for the EIMEA Region 2Accuray Hires General Manager for the EIMEA Region 3Accuray Hires General Manager for the EIMEA Region 4
(Date:6/20/2013)... 20, 2013 Anant Goel, CEO at ... to empower children and adults with skills of the 21st ... that form the foundation for success in the new millennium. ... having access to technology does not automatically make us the ... for work, businesses, and life." , The ...
(Date:6/20/2013)... 20, 2013 As a key researcher ... Navneet Tyagi has remained closely linked to neurodegenerative ... of scientific research that Tyagi has participated in, he ... onset of these severe and mysterious neurological conditions. It ... researchers will be able to understand about the nature ...
(Date:6/20/2013)... Washington, DC (PRWEB) June 20, 2013 ... exchanges, the executive director of the Maryland Health Benefit ... Hub — “something that many in the industry consider,” ... post on AISHealth.com, “as mythical as unicorns and ... actually connected to the Federal Data Services Hub live,” ...
(Date:6/20/2013)... Mobile, a leading manufacturer and distributor of wholesale-direct-to-consumer ... of 16GB version of the Mini Studio Android tablet. ... tablet that is a direct competitor to the iPad ... it will be launched at promotional price at $121 ... Mini STUDIO is part of the Handgiftbox.com “STUDIO Series,” ...
(Date:6/20/2013)... 2013 Emotional abuse expert and author, ... and confronting tactics used by emotional abusers. In ... and not being spoken to for days, being blamed ... experienced these behaviors and more in her marriage to ... marriage for 13 years because she did not realize ...
Breaking Medicine News(10 mins):Health News:RKNet Studio Launched Online Website for Fun Games, Brain Training and Cognitive Skills Development 2Health News:RKNet Studio Launched Online Website for Fun Games, Brain Training and Cognitive Skills Development 3Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 2Health News:Navneet Tyagi Supports Continued Efforts for Alzheimer Detection Procedures 3Health News:Federal Data Services Hub Does Exist, AISHealth.com Blog Post Reports 2Health News:Android Tablet PC Mini Studio with Android 4.1 with 16GB is Here at $121 Only at Handgiftbox.com 2Health News:Lisa Kroulik Empowers Women to Recognize Emotional Abuse in Intimate Relationships 2
... 2007)Uninsured patients in publicly funded community health centers face ... a new study finds. Whats more, this is even ... patient does in fact need these services. Conversely, community ... easier time accessing services. , Often times, people ...
... Research here shows that an obscure form of RNA, ... an important role in human cancer. , These ultraconserved ... but a new report in the September issue of the ... case. , The study found that UCRs, like classic ...
... Calif., Sept. 11 Cepheid (Nasdaq:,CPHD) will present ... the St. Regis Hotel, San Francisco, on Sept. ... Chief Financial Officer, John Sluis will present,at 9:30 ... audio webcast of the presentation, along with,accompanying presentation ...
... Jacobs Engineering,Group Inc. (NYSE: JEC ) announced today ... provide owner-engineer support for a new 220-bed,53,000 square meter ... for cancer identification and treatment. Officials did not ... investment cost for the new hospital is over Euro ...
... Industries Corporation (OTC Pink Sheets: CBIU), a leading,company ... new,series of biological nanometer cosmetics products named "U-SOGNO" ... experiments. The,name comes from the Italian word -- ... -- "One,s Dreams Coming True." The new ...
... Availability of Monte Carlo Dose Calculation Software Announced ... European Radiation Oncology Meeting in Barcelona, BARCELONA, Spain, ... global leader in the field of radiosurgery,announced today that ... from the U.S. Food and Drug Administration and is,now ...
Cached Medicine News:Health News:Uninsured community health center patients often have difficulty accessing specialty services 2Health News:Uninsured community health center patients often have difficulty accessing specialty services 3Health News:New class of RNA molecules may be important in human cancer 2Health News:Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference 2Health News:Jacobs Receives Contract for New Hospital Project in Belgium 2Health News:China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 2Health News:China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China 3Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 2Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 3Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 4Health News:Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery 5
... is a non-invasive massage machine for ... the circulatory system. Extraordinary results are ... action, which combines vertical and parallel ... percussion, gyratory massage, deep tissue mobilization, ...
The Ritter 204 Manual Exam Table. Featuring the latest in design, comfort and functionality in a manual exam table, it truly offers efficient patient care....
... 622 and 623 High-Low Examination Tables deliver the ... you. Many different types of patients can ... how to get on the exam table. Being ... ,can increase a patients comfort during the exam, ...
... MegaPeel microdermabrasion systems offer many features that ... save you time and money. Because our ... easy to use and maintain, you spend ... your microdermabrasion equipment. MegaPeel microdermabrasion systems are ...
Medicine Products: